Watson Pharmaceuticals, Inc.

News and overview for Watson Pharmaceuticals, Inc.

Watson Reports Third Quarter 2009 GAAP EPS of $0.55; Adjusted EPS of $0.66 [Press Release]
PRNewswire | 20 days 2 hours 56 minutes ago
MORRISTOWN, N.J., Nov. 4 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.


Watson Names Robert A. Stewart Senior Vice President, Global Operations [Press Release]
PRNewswire | 8 days 3 hours 26 minutes ago
...Baxter International. Watson Pharmaceuticals, Inc. is a leading global...photodesk@prnewswire.com Watson Pharmaceuticals, Inc. CONTACT: Investors...355-8483, both of Watson Pharmaceuticals, Inc.


Watson to Present at Credit Suisse Healthcare Conference [Press Release]
PRNewswire | 17 days 18 hours 26 minutes ago
...PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical...at the same locations. Watson Pharmaceuticals, Inc. is a global leader in the...photodesk@prnewswire.com Watson Pharmaceuticals, Inc.


Watson Announces Presentation Time Change at Credit Suisse Healthcare Conference [Press Release]
PRNewswire | 13 days 13 hours 14 minutes ago
...PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty...the same locations. Watson Pharmaceuticals, Inc. is a global leader in...photodesk@prnewswire.com Watson Pharmaceuticals, Inc.


Watson and Barr Settle Lawsuit Over Oxytrol(R) [Press Release]
PRNewswire | 27 days 4 hours 26 minutes ago
...PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical...certain circumstances. Watson Pharmaceuticals, Inc., is a global leader in...photodesk@prnewswire.com Watson Pharmaceuticals, Inc.


Watson Pharmaceuticals' 3rd-quarter profit falls 11 percent on higher taxes, charges
Sun (Baltimore), The | 20 days 5 hours 48 minutes ago
Drug developer Watson Pharmaceuticals Inc. said Wednesday its profit fell 11 percent in the third quarter as higher taxes and charges offset a revenue boost.


Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for Over-the-Counter Use [Press Release]
PRNewswire | 88 days 1 hour 24 minutes ago
...PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty...the-counter use. Watson Pharmaceuticals, Inc. is a global leader in...photodesk@prnewswire.com Watson Pharmaceuticals, Inc.


Watson Names R. Todd Joyce Senior Vice President and Chief Financial Officer; Succeeds Mark W. Durand [Press Release]
PRNewswire | 25 days 4 hours 56 minutes ago
...from Golden Gate University. Watson Pharmaceuticals, Inc., is a global leader in the...including but not limited to Watson's Quarterly Report on Form...photodesk@prnewswire.com Watson Pharmaceuticals, Inc.


Watson 3Q profit falls 11 percent on taxes, costs
Richmond Times-Dispatch (Va.) | 20 days 5 hours 55 minutes ago
MORRISTOWN, N.J. (AP) -- Drug developer Watson Pharmaceuticals Inc. said Wednesday its profit fell 11 percent in the third quarter as higher taxes and charges offset a revenue boost.


Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands [Press Release]
PRNewswire | 64 days 9 hours 22 minutes ago
...Pharmaceuticals. Prior to joining Watson, he spent sixteen years at Sandoz...increasing responsibility. Watson Pharmaceuticals, Inc. is a global leader in the development...photodesk@prnewswire.com Watson Pharmaceuticals, Inc.


Watson to Host Third Quarter 2009 Earnings Conference Call and Webcast [Press Release]
MarketWire | 42 days 4 hours 26 minutes ago
MORRISTOWN, NJ -- (Marketwire) -- 10/13/09 -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the Company intends to release its third quarter 2009 financial results on Wednesday, November 4, 2009 prior to the open of the U.S. financial markets. The Company will also host a conference call and webcast at 8:30 a.m. Eastern Standard Time on November 4, 2009 to discuss its financial results and provide an update on the Company's outloo...


Watson Pharmaceuticals and Arrow Group Receive FTC Second Request [Press Release]
PRNewswire | 109 days 22 hours 55 minutes ago
...PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical...second half of 2009. Watson Pharmaceuticals, Inc. is a global leader in the...photodesk@prnewswire.com Watson Pharmaceuticals, Inc.


Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG [Press Release]
PRNewswire | 113 days 1 hour 25 minutes ago
...PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty...to IMS sales data. Watson Pharmaceuticals, Inc. is a global leader in...photodesk@prnewswire.com Watson Pharmaceuticals, Inc.





 1  2  3  4  5  6  7  8  9  10   Next >

141 Results

Sign up for UN Wire



UN Wire is a FREE daily e-mail newsletter covering the United Nations and the World. Aggregating the most important news from hundreds of top international sources, UN Wire provides the latest news and information you need to be an informed citizen. Learn more

Company Overview


Company: Watson Pharmaceuticals, Inc.
Industry: Generic Drugs
Website: http://www.watsonpharm.com

Watson Pharmaceuticals tries to have the best of both worlds, with operations in the US generics market and the higher-profit-margin branded drug business. The company's broad generics portfolio of about 140 products includes treatments for hypertension and pain, as well as smoking cessation products, antidepressants, and oral contraceptives. Its line of about 25 branded drugs focuses on urology and nephrology; it markets its branded products, including treatments for iron deficiency anemia and overactive bladder, to specialist physicians in the US. Additionally, Watson distributes its own and third-party products to independent pharmacies and health care providers through its Anda and Valmed subsidiaries.


Key Numbers

Sales in U.S. Dollars (mil.) 2,535.5 (2008)
One-year % Growth in Sales 1.6 (2008)
Net Income in U.S. Dollars (mil.) 238.4 (2008)
One-year % Growth in Net Income 69.0 (2008)
Number of Employees 5,070 (2008)
One-year % Growth in Number of Employees -10.1 (2008)
Fiscal Year-End December